Community Practice Connections: 2nd Annual International Congress on Oncology Pathology is organized by Physicians' Education Resource, LLC and will be held from Aug 31, 2018 - Aug 31, 2019.
The target audience for this medical event is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of patients with cancer are also invited to participate. This CME Conference has been approved for a maximum of 1.5 Credits.
Description:
Recent advancements in the understanding of the role of distinct phenotypic and genotypic tumor characteristics have created the potential for oncologists and pathologists to hone management plans and improve patient outcomes. Information on appropriate testing methodology and strategies to best use the results of those tests can help to optimize your clinical decision making. As the volume and pace of emerging clinical trial findings pertaining to actionable treatment targets for your patients continues to increase, this educational activity has been designed to provide the latest information on key topics in pathology that can readily be applied to clinical practice in a variety of settings. This activity is intended to facilitate awareness of recent advancements in the field of cancer pathology and enhance multidisciplinary collaboration. Video commentary from leading clinical experts in oncology and pathology will provide you with their perspectives on critical topics in pathology assessment of malignancies commonly encountered in clinical practice, and the clinical implications of those assessments.
Learning Objectives
Upon completion of this activity, you should be better prepared to:
• Identify recent advancements to understand current and emerging biomarkers among commonly encountered malignancies
• Analyze pathology-associated disparities and variances in care for patients with cancer
• Apply current clinical evidence and evolving guidelines in cancer pathology to the tailoring of patient testing and treatment protocols
• Formulate multidisciplinary strategies to optimize cancer diagnosis and management
• Outline the roles of genomic and targeted assays in management of patients with cancer
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved